Organization and Basis of Presentation - Summary of Company's Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Sales	$ 37,895	$ 29,512
Cost of sales	9,566	8,827
Gross profit	28,329	20,685
Operating Expenses [Abstract]
Total operating expenses	39,003	31,355
Loss from operations	(10,674)	(10,670)
Nonoperating Income (Expense) [Abstract]
Interest expense	(6)	(6)
Interest and other income	2,508	1,585
Loss before income taxes	(8,172)	(9,091)
Income tax expense	18	9
Net Income (Loss)	(8,190)	(9,100)
Commercial [Member]
Operating Expenses [Abstract]
Total operating expenses	21,174	16,475
General and Administrative [Member]
Operating Expenses [Abstract]
Total operating expenses	7,462	6,849
Research and Development [Member]
Operating Expenses [Abstract]
Total operating expenses	9,056	6,150
Clinical and Regulatory [Member]
Operating Expenses [Abstract]
Total operating expenses	$ 1,311	$ 1,881